Literature DB >> 21568233

Preventing hypoglycemia with novel technology and flexible therapy.

Judit Dunai1, Garry S Tobin.   

Abstract

Diabetes is increasing at an alarming rate. Treatment-associated hypoglycemia is a major limitation to achieving glycemic control in diabetes. Appropriate use of new technology and flexible treatment regimens, especially in those with defined risk factors, may decrease the frequency of hypoglycemia.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21568233      PMCID： PMC6189163     

Source DB:  PubMed          Journal:  Mo Med        ISSN： 0026-6620


  21 in total

1.  Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps.

Authors:  Claresa Levetan; Laura L Want; Christian Weyer; Susan A Strobel; John Crean; Yan Wang; David G Maggs; Orville G Kolterman; Manju Chandran; Sunder R Mudaliar; Robert R Henry
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

2.  Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.

Authors: 
Journal:  Am J Med       Date:  1991-04       Impact factor: 4.965

3.  Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes.

Authors:  C Abraira; J Colwell; F Nuttall; C T Sawin; W Henderson; J P Comstock; N V Emanuele; S R Levin; I Pacold; H S Lee
Journal:  Arch Intern Med       Date:  1997-01-27

4.  Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group.

Authors: 
Journal:  Diabetes       Date:  1997-02       Impact factor: 9.461

5.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Authors:  Anushka Patel; S MacMahon; J Chalmers; B Neal; M Woodward; L Billot; S Harrap; N Poulter; M Marre; M Cooper; P Glasziou; D E Grobbee; P Hamet; S Heller; L S Liu; G Mancia; C E Mogensen; C Y Pan; A Rodgers; B Williams
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

Review 6.  Practical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes Management.

Authors:  P Aschner; E Horton; L A Leiter; N Munro; J S Skyler
Journal:  Int J Clin Pract       Date:  2010-02       Impact factor: 2.503

7.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

8.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.

Authors: 
Journal:  Diabetologia       Date:  2007-04-06       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.